Skip to content First 100 Early AdoptersStandard $997/mo $297/mo for lifeSave $700/mo$8,400/yearJoin the waitlist →

How we help

Every program your members ask for — under your brand

Launch any of these as a branded, cash-pay program. An independent, board-certified network licensed in all 50 states evaluates and prescribes; you set retail and keep the margin on labs, telehealth and supplements.

$0 to start$0 until you're liveno cardcancel anytime

WellStaq is a white-label telehealth platform that lets programs connect bloodwork, licensed doctor consultations, eligible 503A pharmacy services, and optional supplements under their own brand. Independent clinicians control care; compounded drugs are not FDA-approved.

A recognizable model. Your own brand.

Build the Ro and Hims of programs — and own it

Think Function Health-style lab memberships and Hims-style access to care, brought together under your own brand. Start with bloodwork, connect members with a licensed doctor, then support appropriate next steps. These are business-model references, not affiliations; services and results differ.

The model members recognize

  • Online telehealth visits at scale
  • Provider-guided follow-up when appropriate
  • Branded supplements and monthly memberships

Familiar access to care, with transparent clinical roles.

Your version

Bloodwork first. Your brand throughout.

  • White-label telehealth and eligible 503A pharmacy pathways
  • + blood labs and genetic reports
  • + your brand and connected member experience
  • + optional supplements and your own coaching

Launch in weeks, for a flat fee — no raise required.

Three paths — and why partners pick Wellstaq

You're really choosing between sending patients to someone else's brand, building it all yourself, or owning the model on Wellstaq.

Refer out to Function Health, Ro & Hims

  • You lose the patient to their brand
  • $0 recurring revenue to you
  • The member experience carries their brand
  • Services and availability vary by provider

Build it yourself

  • Build and maintain your own technology
  • Arrange clinical, privacy, and legal support
  • You vet compounders and track 50-state rules
  • You build labs, pharmacy, app and supplements
Best option

Build it on Wellstaq

  • Patients stay under your brand
  • Recurring revenue you keep — flat $997/mo, live in weeks
  • An independent 50-state network owns clinical + prescribing
  • Labs, genetics, telehealth, 503A Rx and supplements — not just programs
  • Earn from lawful products and nonclinical services; clinical billing stays separate

How the economics work

One platform fee. Build value beyond the test.

Standard $997/mo. First 100 Early Adopters: $297/mo with a lifetime price lock. Save $700/month — $8,400 every year on platform access. Lead with bloodwork, connect members with licensed telehealth and eligible 503A pharmacy services, and offer optional supplements, your own qualified coaching, and memberships. WellStaq takes 0% of your sales. Lab, clinical, pharmacy, product, and operating costs are separate; clinical fees and any management arrangements must follow applicable rules. No prescription commissions or earnings are promised.

Launch your first program under your own brand.

Save $700/month — $8,400/year. The first 100 Early Adopters to sign up get $297/mo locked in for life, instead of standard $997/mo. Join the free waitlist for your invitation when enrollment opens.

$0 to start$0 until you're liveno cardcancel anytime

WellStaq provides white-label telehealth technology and brand infrastructure, not medical care. Independent licensed providers make clinical and prescribing decisions. Eligible 503A pharmacy services require a valid patient-specific prescription and compliance with applicable requirements; availability varies. Compounded drugs are not FDA-approved. Provider and pharmacy identities remain disclosed. Health data is used only for permitted purposes with required safeguards and authorizations. Billing, marketing, privacy, and management arrangements need state-specific legal review. No health or earnings outcome is guaranteed.